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Molecular Roots of Degenerate Specificity
in Syntenin’s PDZ2 Domain: Reassessment
of the PDZ Recognition Paradigm
pocket of the PDZ domain). Those domains that are
grouped together as class I bind Ser or Thr in P2 and
a hydrophobic residue in P0, so that the target sequence
motif is -S/T-X-φ (φ represents hydrophobic residues
and  represents aromatic residues). Class II domains
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The Cancer Center bind another hydrophobic residue at P2 (-φ-X-φ), while
a negatively charged residue at P2 defines class IIIUniversity of Virginia
Charlottesville, Virginia 22908 interactions (-D/E-X-φ). This simple model is unable to
explain an increasing number of PDZ-mediated interac-
tions that do not conform to this canonical type of recog-
nition. To account for them, new classes of PDZ domainsSummary
are being proposed to extend the model. For example,
PDZ1 of Mint1 has been termed “novel class III” (-E/D-Crystal structures of the PDZ2 domain of the scaffold-
X-W-C/S) (Maximov et al., 1999), and PDZ3 of hINADLing protein syntenin, both unbound and in complexes
has been placed in “class IV” (-X--D/E) (Vaccaro andwith peptides derived from C termini of IL5 receptor
Dente, 2002). These new classes of PDZ domains recog-( chain) and syndecan, reveal the molecular roots of
nize P1 instead P2. To further complicate the issue,syntenin’s degenerate specificity. Three distinct bind-
some PDZ domains recognize more than one class ofing sites (S0, S1, and S2), with affinities for hydropho-
the C-terminal sequence motif. CIPP PDZ3 binds neu-bic side chains, function in a combinatorial way: S1
rexin (class II) and the NMDA receptor (class I) (Kurschnerand S2 act together to bind syndecan, while S0 and
et al., 1998), and the third PDZ domain of hINADL bindsS1 are involved in the binding of IL5R. Neither mode
the sequences --D-φ (class II) and -X--D sequenceof interaction is consistent with the prior classification
(class IV) (Vaccaro and Dente, 2002), while MINT1 PDZ1,scheme, which defined the IL5R interaction as class
hINADL PDZ5, and Par6 PDZ domains bind ligands withI (-S/T-X-φ) and the syndecan interaction as class II
sequences -D-H-W-C (novel class III) and -E-Y-Y-V(-φ-X-φ). These results, in conjunction with other
(class II) (Bezprozvanny and Maximov, 2001). The erbinemerging structural data on PDZ domains, call for a
PDZ domain binds the receptor ErbB2 (class II) andrevision of their classification and of the existing model
LET-23 peptide (class I) (Borg et al., 2000). While dualof their mechanism.
specificity is not rare in PDZ binding, there is no general
model accounting for it.
Introduction Syntenin, first identified as a syndecan binding pro-
tein, contains a tandem of PDZ domains, which demon-
PDZ domains (postsynaptic density protein, disc large, strate degenerate specificity (Grootjans et al., 1997). In
and zonula occludens) occur within numerous multi- addition to syndecan, there are currently at least 10
domain cytosolic proteins and mediate their binding to binding partners reported for syntenin, including class
receptors and channels, thereby serving as a mem- I proteins such as interleukin 5 receptor subunit (IL5R)
brane-associated scaffold for the assembly of signaling (-D-S-V-F) (Geijsen et al., 2001), neuroglian (-Y-S-L-A)
complexes (Harris and Lim, 2001; Hung and Sheng, (Koroll et al., 2001), proTGF- (-E-T-V-V) (Fernandez-
2002). Over 440 domains of this type have been identi- Larrea et al., 1999), and neurofascin (-Y-S-L-A) (Koroll
fied so far in the human genome, and they are also et al., 2001); class II molecules such as syndecan
abundant in other organisms (Sheng and Sala, 2001). (-E-F-Y-A), ephrin B (-Y-Y-K-V) (Lin et al., 1999; Torres
PDZ domains are structurally conserved modules about et al., 1998), Eph A7 (-G-I-Q-V) (Torres et al., 1998), PTP-
90 amino acids in size. The majority are believed to (-G-Y-I-A) (Iuliano et al., 2001), and neurexin I (-E-Y-Y-V)
function by binding the C-terminal tail of the target pro- (Grootjans et al., 2000); and the class III protein merlin
tein in a structurally conserved groove between the 2 (-F-E-E-L) (Jannatipour et al., 2001). In principle, such
strand and the 2 helix (Doyle et al., 1996). The terminal diversity of interactions could be caused by degenerate
carboxylate of the target is anchored via hydrogen specificity or alternatively by cooperative effects of two
bonds from three main chain amides within a conserved PDZ domains. We recently showed that syntenin’s two
glycine-rich loop, a fingerprint of the PDZ fold. Early PDZ domains show degenerate and noncooperative
data derived from crystallographic and NMR studies binding (Kang et al., 2003). The second PDZ domain
suggested a general model of sequence pattern recog- (PDZ2) binds IL5R (class I) and syndecan-4 (class II)
nition, in which the peptide is bound in an extended peptides, in spite of dramatically dissimilar sequences,
conformation so that two side chains, P0 and P2, point with the dissociation constants of 1.9 M and 2.3 M,
into the groove of the PDZ domain and account for respectively. Mutational studies also show that PDZ2
specificity (P0 denotes the C-terminal residue of the has binding capacity for both class I and class II pep-
bound peptide and Pn denotes the nth amino acid up- tides (Grootjans et al., 2000; Koroll et al., 2001). In order
stream of it; Sn denotes the corresponding binding to elucidate the molecular basis for the dual specificity
of the PDZ2 domain of syntenin, we determined the
crystal structures of the PDZ2 domain alone and in com-*Correspondence: zsd4n@virginia.edu
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Table 1. Crystallographic Data
PDZ2 PDZ2-Syndecan-4 PDZ2-IL5RData Set
Experimental Data
Wavelength () 1.54178 0.97946 0.97946 0.97946
Space group P21 P21 C2 C2221
Unit cell parameters (A˚, )
a 25.27 25.29 58.34 53.72
b 42.54 42.57 54.44 55.98
c 31.06 31.04 50.22 51.09
 108.8 108.7 98.7 90.0
Resolution (A˚) 25.0–1.60 13.0–1.10 50.0–1.85 20.0–1.25
(1.66–1.60)a (1.14–1.10) (1.92–1.85) (1.29–1.25)
Total reflections 21,360 58,393 46,421 155,256
Unique reflections 6,600 (186) 18,559 (275) 12,987 (1,108) 20,850 (1,611)
Completeness (%) 79.8 (22.9) 73.3 (11.0)b 97.4 (83.7) 95.7 (75.0)
Rsym (%)c 5.8 (17.0) 4.2 (17.0) 4.9 (41.3) 5.1 (49.6)
Average I/	 (I) 22.7 (3.62) 28.5 (3.46) 25.8 (2.86) 33.5 (2.15)
Refinement Details
Resolution (A˚) 21.27–1.60 12.16–1.24 49.39–1.85 19.39–1.35
Reflections (working) 6,290 15,685 12,001 16,171
Reflections (test) 307 851 985 848
Rwork (%)d 11.9 11.3 17.5 17.6
Rfree (%)d 16.6 15.3 22.6 21.2
Number of waters 181 173 145 144
Rms deviation from ideal geometry
Bonds (A˚) 0.015 0.013 0.012 0.016
Angles () 1.48 1.63 1.82 2.13
Average B factor (A˚2)
Main chain 11.42 8.32 16.01 17.19
Side chain 12.69 10.15 20.50 21.50
Waters 26.41 22.21 39.86 39.93
a The numbers in parentheses describe the relevant value for the last resolution shell.
b Completeness at resolution 12.16–1.24 (1.30–1.24) used for refinement is 93.1% (73.4%)
c Rsym 
 |Ii  I|/I where Ii is the intensity of the ith observation and I is the mean intensity of the reflections.
d Rwork 
 ||Fobs|  |Fcalc||/ |Fobs|, crystallographic R factor, and Rfree 
 ||Fobs| |Fcalc||/|Fobs| when all reflections belong to a test set of randomly
selected data.
plexes with an IL5R C-terminal peptide (ETLEDSVF) of Gly207 through an ordered water molecule. The main
chain amide of the C-terminal residue donates a hydro-and a syndecan-4 peptide (TNEFYA). The structures
were refined to 1.24 A˚, 1.35 A˚, and 1.85 A˚ resolution, gen bond to the carbonyl oxygen of Phe211 in the 2
strand. The carbonyl oxygen of Phe (P2) interacts withrespectively. These structures show how syntenin’s
PDZ2 can accommodate different peptides and call for the amide group of Phe213, while its amide donates a
hydrogen bond to the carbonyl oxygen of the samea revision of the established paradigm of PDZ domain
classification. residue. The C-terminal Ala (P0) and Phe (P2) of the
syndecan peptide interact with PDZ2 in agreement with
the canonical model of class II, as exemplified by theResults and Discussion
structure of hCASK (Daniels et al., 1998). However, the
methyl group of Ala (P0) is much smaller than the sizeSyndecan Binding Involves Interaction with Tyr1
of the hydrophobic pocket at S0, which is formed mostlyThe crystal structure of the PDZ2 domain with a bound
by Val209, Phe211, Phe213, and Leu258 (Figure 1B). Insyndecan-4 C-terminal hexapeptide was refined at
contrast, the benzene ring of Phe (P2) fits well in the1.85 A˚ resolution to a crystallographic R value of 17.5%
corresponding S2 pocket formed by Phe213, Asp251,and Rfree of 22.6% (Table 1). The structure contains a
and Ala255.noncrystallographic dimer of PDZ2-peptide complexes
Interestingly, there is an additional interaction involv-in the asymmetric unit. In both complexes, the structures
ing Tyr (P1), which is lodged into the S1 pocket cush-of the bound syndecan-4 peptides were identical within
ioned by His208, Ileu212, and Val222. The aromatic ringexperimental error, with the average isotropic tempera-
is involved in an off-center stacking interaction withture factor (B factor) of 30.9 A˚2 and 31.4 A˚2, respectively.
His208. Other syntenin PDZ2 binding proteins, neurexinIn general, the interaction between the PDZ2 and the
I (class II), and neuroglian (class I) also have Tyr in thepeptide conforms to the classical model of a strand
P1 position (Grootjans et al., 2000; Koroll et al., 2001).insertion between the 2 strand and 2 helix of the
The equal importance of the Phe (P2) and Tyr (P1)PDZ domain (Figure 1A). The terminal carboxylate of the
interactions for recognition by syntenin’s PDZ2 is under-peptide accepts three hydrogen bonds from the amide
scored by studies showing that mutations to Ala of eithernitrogens of Val209, Gly210, and Phe211. There is an
additional indirect interaction with the carbonyl oxygen of the two residues abolish binding to syntenin (Groot-
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Figure 1. Comparison of Syntenin PDZ2 Structures Binding Syndecan-4 Peptide and Interleukin 5 Receptor  Subunit
(A) Ribbon diagram of the syntenin PDZ2 bound to the syndecan-4 peptide (TNEFYA). A 2mF0  DFC electron density map calculated at 1.85 A˚
resolution and contoured at 1.0	 is shown around the ligand.
(B) Molecular surfaces of syntenin PDZ2 showing three hydrophobic binding pockets and the syndecan-4 peptide. The three binding pockets
are circled. The three C-terminal residues are shown in the C trace cartoon of the peptide. The side chains of tyrosine (1) and phenylalanine
(2) occupy the two pockets S1 and S2, while alanine (0) only occupies a portion of S0.
(C) Ribbon diagram of the syntenin PDZ2 bound to the interleukin 5 receptor  subunit peptide (ETLEDSVF). A 2mF0  DFC electron density
map calculated at 1.35 A˚ resolution and contoured at 1.0	 is shown around the ligand.
(D) Molecular surfaces of syntenin PDZ2 showing three hydrophobic binding pockets and the interleukin 5 receptor  subunit peptide. The
three binding pockets are circled. The three C-terminal residues are shown in the C trace cartoon of the peptide. The side chains of
phenylalanine (0) and valine (1) of the peptide are located in pockets S0 and S1, while that of serine (2) is out of pocket S2. The same
orientation is used for (A) and (B) or (C) and (D). Figures were made using MOLSCRIPT (Kraulis, 1991) and Pymol (DeLano Scientific). Strand
1 (197–203); 2 (210–214); 3 (216–222); 4 (234–242); 5 (244–246); 6 (A263–270); Helix 1 (225–231); 2 (250–260).
jans et al., 1997). Thus, the interaction of PDZ2 with of the receptor has Ser in the P2 position and Phe in
the P0 position. However, the sequences of synteninsyndecan depends primarily on the side chains of resi-
dues in P1 and P2 rather than P0 and P2, as the classi- PDZ domains do not resemble a typical class I domain.
In particular, there is a notable absence of a histidinecal model implies.
at the beginning of helix 2, which normally hydrogen
bonds to the hydroxyl of Ser or Thr (P2). In an effort toThe Interaction of IL5R with Syntenin
Does Not Involve Ser2 characterize the details of the IL5R interactions with
syntenin, we crystallized and solved the structure ofThe interaction of syntenin with IL5R was originally
reported as class I, because the C-terminal sequence the PDZ2 domain with an octapeptide derived from the
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C-terminal sequence of IL5R. The crystals of the com-
plex allowed for X-ray data collection to a resolution of
1.35 A˚ (Table 1). The atomic model, refined to a crystallo-
graphic R value of 17.6% (Rfree 21.2%), shows how the
C-terminal carboxylate group of Phe (P0) of the peptide
is bound in a way analogous to that seen in the syndecan
complex, while its benzene ring fills the S0 pocket (Fig-
ures 1C and 1D). However, Ser (P2) does not directly
interact with the PDZ2 domain as suggested by the
classical model. The side chain of Val (P1) fits into the
hydrophobic S1 pocket, and the carbonyl oxygen of
Ser (P2) is hydrogen bonded through a water molecule
to the Ile212 main chain nitrogen. There are no further
interactions, and the electron density for the peptide
fades beyond P4. Except for the interaction of Phe
(P0), the peptide’s backbone does not fully occupy the
binding groove as is seen in other complexes, leaving
the S2 site empty. Similar interaction of these three
C-terminal residues was also found in the crystal struc-
ture of the syntenin PDZ tandem-IL5Rpeptide complex
(data not shown, our PDB entry 1OBZ). It has been
shown by mutational studies that with the exception
of the C-terminal Phe, no other residue is vital for the
interaction of IL5R with syntenin (Geijsen et al., 2001).
This is in agreement with our results but does not sup-
port the classical class I recognition mechanism. In con-
trast, the structure reveals some similarities to the con-
formation observed in erbin-ErbB2 peptide complex
(Birrane et al., 2003). Failure of Val (P2) to form a typical
class I interaction with His at 2 helix causes the dis-
placement of the peptide backbone away from the 
helix. In the complex of erbin and phosphorylated ErbB2
peptide (EpYLGLDVPV) complex, no density is observed
beyond P5, leaving its other binding pocket at the 2-
3 loop empty.
The Structure of Unbound PDZ2 Suggests
Additional Recognition Mechanisms
PDZ domains show high affinity toward terminal car-
boxyl groups of peptides, and in the absence of target
peptides, isolated PDZ domains will often bind their own
C-terminal tails. The crystal structures of the hCASK
PDZ, NHERF PDZ1, and GRIP1 PDZ6 domains show
how the peptide binding grooves are occupied by the
C-terminal tails of neighboring molecule, mimicking the
recognition of the peptide ligand (Daniels et al., 1998;
Im et al., 2003; Karthikeyan et al., 2001a). In a similar
way, the crystal structure of the uncomplexed PDZ2
domain, refined at 1.24 A˚ resolution to a crystallographic
R value of 11.3% (Rfree 15.3%), shows an interesting
interaction between adjacent molecules (Table 1 and
Figure 2A). This interaction suggests that PDZ2 is capa-
ble of yet another mode of molecular recognition, in
Figure 2. Syntenin PDZ2 Interaction with Its Neighbor Molecular addition to the classic mode of strand insertion.
The PDZ2 construct used here terminates at residueShows Novel PDZ Binding
Phe273, rather than Met270, as is the case with the(A) Crystal packing of syntenin PDZ2. Each C terminus serves as a
ligand for a neighboring PDZ2 molecule.
(B) Ribbon diagram of syntenin PDZ2 bound to the C-terminal and
internal sequences of its neighbor molecule. A 2mF0  DFC electron
residues are shown in the C trace cartoon of bound residues. Thedensity map calculated at 1.24 A˚ resolution and contoured at 1.0	
side chains of phenylalanine (0) and alanine (1) of the C terminusaround the residues bound in the PDZ domain.
reside in pockets S0 and S1, while that of methionine (3) is in pocket(C) Molecular surfaces of syntenin PDZ2 showing three hydrophobic
S2. The same orientation is used for (B) and (C). Figures were madebinding pockets and the residues of neighboring molecule binding
using MOLSCRIPT (Kraulis, 1991) and Pymol (DeLano Scientific).at the pockets. The three binding pockets are circled. The three
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crystal structures of the two above described com- the S1 pocket, are equivalent to His208 and Val222 of
syntenin PDZ2.plexes. (Chronologically, this structure was done first,
and the construct was then truncated to circumvent Another example is the erbin PDZ domain, normally
defined as a class I because of the His at the beginninginter-PDZ2 interactions and inhibition of peptide bind-
ing.) One molecule of PDZ2 binds the C-terminal Phe of the 2 helix and because of the target motif -S/T-
X-φ. Interestingly, this domain does not bind ErbB4of its crystallographic neighbor in a manner identical to
that observed for the IL5R (Figures 2B and 2C). The (-N-T-V-V) (Borg et al., 2000), but interacts with the C
termini of -catenin, p0071, and ARVCF, which all sharepreceding residues are out of the binding groove, and
there is no interaction of P2 at S2. Compared to either the sequence -D-S-W-V (Laura et al., 2002). Further-
more, Trp was exclusively selected for P1 for the erbinthe syndecan or IL5R bound structures, the binding
groove is not altered except for the side chain of Ile212, PDZ domain by phage display peptide library screening.
The NMR solution structure of the erbin PDZ domainwhich rotates to accommodate the C terminus of the
neighboring molecule. In addition to the interaction in- with the phage-optimized peptide (AcTGWETWV) re-
veals canonical interactions of P0 and P2 residues, asvolving the C-terminal Phe, the N-terminal portion of the
same molecule also interacts with the binding groove. well as an additional interaction involving Trp (P1),
whose side chain reaches across strand 2 and insertsThis is possible because the C terminus and N terminus
of PDZ2 are close to each other and form a structural between the side chain of Arg49 and Gln51 at the end of
3 strand (Skelton et al., 2003). Clearly, a more accurateepitope. The side chain of the third residue Met binds
into the S2 site, so that its methyl group is in a very description of the target motif for erbin would be -S/T-
W-φ, highlighting the preference at P1 for Trp.close contact with the aromatic ring of Phe213. A salt
bridge forms between carboxyl group of an Asp, which In syntenin’s PDZ2, all three binding pockets (S0, S1,
and S2) have an apparent affinity for hydrophobic resi-follows the Met, and amino group of Lys214 in 2 strand
of the adjacent molecule. Thus, in this case, syntenin’s dues (-φ-φ-φ). These pockets function in a combinato-
rial way to bind peptides from different targets. ThisPDZ2 domain shows affinity for a structural epitope,
rather than a sequence motif. It is very probable that interplay of the three sites appears to endow PDZ2 with
the ability to bind diverse but specific sequence motifs.this mode of recognition also occurs in nature, and that
the two binding sites (S0 and S2) may bind amino acids, The complex of syntenin’s PDZ2 domain with synde-
can-4 peptide, previously classified as class II interac-which need not be adjacent within a short peptide.
tion, involves the recognition of two penultimate resi-
dues, Tyr (P1) and Phe (P2), but not of the side chain
Molecular Basis of Recognition by PDZ Domains of P0 (-φ-φ-X) (Figures 1B and 3C). On the other hand,
Our results, in conjunction with existing literature, call the interaction with the IL5R peptide does not involve
into question the utility of the current model of protein the P2 side chain hydroxyl, unlike other PDZ domains
recognition by PDZ domains and of the rigid classifica- that interact with class I peptides (Figure 1D). Therefore,
tion of PDZ domains based on the identity of P0 and P2 defining the IL5R peptide as class I partner for syntenin
residues of a target peptide (Figure 3A). As shown here, is questionable. Our data suggest that syntenin’s PDZ2
syntenin PDZ2 has three distinct binding pockets (S0, interactions with other so-called class I peptides may
S1, and S2), and the interaction of the P1 residue at also involve binding of P0 and P1 (-X-φ-φ) instead of
the S1 site is as important as the canonical interactions P0 and P2 as the classical model requires (Figure 3D).
at the S0 and S2 sites. Therefore, P1 interaction should All of syntenin’s partners known to bind to PDZ2 have
be included as a general feature of PDZ interaction (Fig- hydrophobic residues in P1.
ure 3B). The importance of the P1 binding is also appar- Our combinatorial model incorporates the classical
ent from studies of other PDZ domains. Both LIN-2 and P0 and P2 interactions (-φ-X-φ) but accounts for all
p55 PDZ domains bind peptides where all three terminal three S sites (-φ-φ-φ) (Figures 3A and 3B). We expect
residues are hydrophobic, including aromatic side chains that the former mode expains syntenin’s interaction with
at both P1 and P2 (Songyang et al., 1997). By phage- ephrin B (-Y-Y-K-V), while the latter may apply to neu-
displayed peptide library screening, PDZ2 of MAGI3 se- rexin (-E-Y-Y-V). This model could also explain the dual
lects Trp as P1 and the side chain of this Trp is critical specificity observed for other PDZ domains. For exam-
for high-affinity binding (Fuh et al., 2000). Model studies ple, the CIPP PDZ3 domain binds NMDA receptors
suggest that the side chain at P1 position reaches (class I) and neurexin (class II). Although the former
across the 2 strand and makes specific contacts with target has a sequence -E-S-D/E-V, the CIPP PDZ3 do-
side chains in the 3 strand. The binding specificity main does not have a His at 2 and it does not bind a
studies of hINADL reveal that PDZ1, 2, 3, and 4 belong related peptide from neuroligin2 (-T-T-R-V) (Kurschner
to class II while PDZ5, 6, and 7 are class I PDZ domains et al., 1998), indicating that the P2 position is not critical,
(Vaccaro et al., 2001). However, except for PDZ7, all in contrast to canonical class I interaction. The SMART
domains in hINADL have some selectivity for P1, and database places this particular PDZ domain in a group
the site-directed mutagenesis of the residues in 3 of that binds a motif --D/E-φ (Bezprozvanny and Max-
hINADL PDZ7 alters the selectivity for P1. The atomic imov, 2001). Applying the combinatorial three-pocket
model of the NHERF PDZ domain complexed with the model helps understand how it can bind NMDA recep-
-Q-D-T-R-L target sequence also reveals recognition tors using P1 and P0 (-S-D/E-V) and neurexin using P2
mediated by the P1 residue: the Arg side chain in this and P0 (-Y-Y-V).
position interacts intimately with Asn22 and Glu43 of Aside from explicit examples of the involvement of
the P1 residue—unaccounted for in the classicalthe PDZ (Karthikeyan et al., 2001b); these residues, lining
Structure
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Figure 3. Schematics of PDZ Interactions
(A) Canonical PDZ binding of C-terminal se-
quence depends on the residues P0 and P2
binding pockets S0 and S2.
(B) All three C-terminal residues are involved
in the interaction to PDZ binding groove.
(C) The C-terminal binding depends on the
binding at S1 and S2 of PDZ as seen in
PDZ2-syndecan-4 peptide complex.
(D) The C-terminal binding depends on the
binding at S0 and S1 as seen in syntenin
PDZ2-interleukin 5 receptor  subunit pep-
tide complex.
(E) Syntrophin PDZ interaction by the resi-
dues from -finger conformation of nNOS.
(F) Interaction of internal residue at pocket
S2 while C-terminal residues binds at S0 as
seen in syntenin PDZ2-PDZ2 interaction.
model—there are examples of the P2 residue not being loop, have further interaction to its target peptide at this
region (Birrane et al., 2003; Kozlov et al., 2002; Walmainvolved, as in the interaction of syntenin’s PDZ2 with
IL5R. The so-called class IV or class III interactions, et al., 2002). We have shown that the PDZ1 domain of
syntenin, which also has a long 2-3 loop, recognizestargeting sequences -X--D/E or -X-W-C, do not show
specificity for P2 (Bezprozvanny and Maximov, 2001; residues upstream of the terminal hexapeptide of merlin,
as exemplified by a significantly higher affinity for octa-Maximov et al., 1999). It is not surprising that the degen-
erate specificity is common among these PDZ domains. than hexapeptide (Kang et al., 2003). However, syntenin
PDZ2 has a short 2-3 loop like PSD-95 PDZ1 andMint1 PDZ1, which has dual specificity for sequences
-E/D-X-W-C/S and -E-Y-Y-V, could bind both types of NHERF PDZ1, and these domains do not interact with
the bound peptides at this loop (Doyle et al., 1996; Kar-sequences by interacting with P1/P0 and P2/P1 pairs,
respectively. The ability of the fifth PDZ domain of hI- thikeyan et al., 2001b, 2002). Thus, the interaction in-
cluding P3 appears to be optional, and it could enhanceNADL (Vaccaro et al., 2001) and PAR6 PDZ domain to
bind the sequences -D-H-W-C and -E-Y-Y-V may be the binding in the absence of, or in addition to, strong
binding at C-terminal three residues.rationalized in a manner similar to the Mint1 PDZ1 inter-
action. However, there may be additional interaction Finally, the recent erbin structures show how a binding
pocket can be targeted by a residue that does not oc-involving the conserved P3, residue, D/E.
We believe that all three S sites described here are cupy the expected sequence position. The crystal struc-
ture with ErbB2 peptide shows that Tyr7 of the peptidekey determinants in the PDZ complex recognition pat-
tern, and any general model should include all three. binds at a site within the 2-3 loop (Birrane et al., 2003).
Interestingly, in the structure with the phage peptideThe binding modes of known PDZ domains, according
to our combinatorial model depicted in Figure 3, are (AcTGWETWV), Trp4 interacts at the same binding site
(Skelton et al., 2003). This implies that a structural epi-summarized in Table 2.
There is also accumulating evidence that residues tope is more important than the sequence for PDZ-pep-
tide interaction. As shown by our structure of syntenin’supstream of the C-terminal tripeptide of the target may
also be involved in the recognition process, putting the PDZ2 and its interaction with its neighboring molecule,
the residues far from the C terminus in sequence canclassical model in even greater peril (Laura et al., 2002;
Songyang et al., 1997; Vaccaro et al., 2001). Although be involved in binding to the S2 pocket by forming a
contiguous structural epitope with the C terminus. Therewe found no interaction with P3 in the syntenin PDZ2
structures, the specificity for P3 is often observed. is also the exceptional example of the recognition of
nNOS -finger, not C terminus, by syntrophin (FigureSome PDZ domains, which have long 2 strand or 2-3
Molecular Basis of Degenerate Specificity of PDZ
851
Table 2. Proposed Binding Modes of PDZ Domains by the Combinatorial Model
The C-Terminal Sequence Motifs
PDZ Domains of Representive Ligands Binding Modea References
Class I (-S/T-X-φ)b
PSD-95 PDZ3 -T-S-V Ac Doyle et al., 1996
NHERF PDZ1 -T-R-L, -S-L-L, -S-F-L, -E-Q-L Ac, Bc Karthikeyan et al., 2001a, 2001b,
2002
Erbin -T-W-V, -V-P-V, -S-W-V Ac, Bc Borg et al., 2000; Laura et al., 2002;
Skelton et al., 2003
hPTP1E -S-A-V Ac Kozlov et al., 2002
Syntrophin -S/T-X-V, S-L-V, T-T-Fd Ac, Bc Hillier et al., 1999; Schultz et al., 1998
MAGI3 PDZ2 -S/T-W-V B Fuh et al., 2000
CIPP PDZ3 -S-D/E-V, -Y-Y-V A, C Bezprozvanny and Maximov, 2001;
Kurschner et al., 1998
Class II (-φ-X-φ)
hCASK -R-E-F, -F-Y-A Ac, C Daniels et al., 1998
Syntenin -F-Y-A, -S-V-F, -Y-Y-V, -Y-K-V A, B, Cc, Dc Geijsen et al., 2001; Grootjans et al.,
1997, 2000; Torres et al., 1998;
this study
GRIP PDZ6 -Y-S-C Bc Im et al., 2003
P55 -Y-F-I, -F-X-X, -Y-Y-F B, C Songyang et al., 1997
LIN-2 -F-F-V/F/A B, C Songyang et al., 1997
Class III (-D/E-X-φ)
nNOS -D-S-V Ad Tochio et al., 1999
Class IV (-X--D/E, -X-W-C/S)
hINADL PDZ3 -W-D-V, -Y-D-W, S-W-E, -S-Y-E B, D Vaccaro et al., 2001
Mint1 PDZ1 -D-W-C, -H-W-C, -Y-Y-V C, D Bezprozvanny and Maximov, 2001;
Maximov et al., 1999
PAR6 -H-W-C, -Y-Y-V C, D Bezprozvanny and Maximov, 2001
hINADL PDZ5 -H-W-C, -Y-Y-V, -V-F-V C, D Bezprozvanny and Maximov, 2001;
Vaccaro et al., 2001
a A, canonical P0 and P2 binding; B, P0, P1, and P2 binding; C, P1 and P2 binding; D, P0 and P1 binding, as shown in Figure 3.
b X denotes any amino acid; φ denotes a hydrophobic residue;  denotes an aromatic residue.
c Structure was solved by X-ray or NMR.
d-finger binding.
3E; Hillier et al., 1999), but the mode we suggest implies such as IL5R and syndecan. We report the crystal struc-
tures of complexes of the second PDZ domain of syn-involvement of internal sequences in addition to the
interaction of the C terminus in PDZ interaction (Fig- tenin, residues 113–270, with the C-terminal peptides
of IL5R and syndecan, solved at 1.35 A˚ and 1.85 A˚ure 3F).
One of the benefits of PDZ classification is the poten- resolution, respectively. These structures reveal how
one PDZ domain interacts with different C-terminal se-tial ability to predict the binding partners for a given
PDZ domain. However, even a correctly predicted single quences of binding targets. Syndecan binds syntenin
mainly by its C-terminal P1 and P2 residues, and IL5RC-terminal sequence motif may not be enough to deter-
mine the binding capacity of any given PDZ domain. For interacts through its C-terminal P0 and P1 residues.
These results not only extend the knowledge of PDZ-successful prediction of multiple binding partners for
PDZ domains, it would be better to characterize the ligand recognition of specific targets but also explain
the general scheme underlying degenerate specificity.PDZ domain by the specificity of its binding pockets,
especially the three pockets for the C-terminal residues, Furthermore, the mode of syntenin PDZ2 interaction
with its neighbor molecule in a crystal of the unboundand account for the likely combinations.
PDZ2 domain (1.24 A˚ resolution) suggests the impor-
tance of a structural epitope for PDZ interactions ratherBiological Implications
than a sequence motif. Based on our results and theProtein-protein interactions are pivotal to cell signaling
results published elsewhere, we propose the combina-events. The PDZ domain is the most ubiquitous protein-
torial model that generalizes the PDZ-ligand interac-protein interaction module found in the human genome,
tions. The new model is likely to predict the possiblewith nearly 500 copies. Numerous multidomain cytosolic
binding of biologically important target molecules moreproteins contain PDZ domains and bind to receptors and
accurately than the current model.channels, thereby serving as a membrane-associated
scaffold for the assembly of signaling complexes. Syn-
Experimental Procedurestenin is a ubiquitous protein containing two PDZ do-
mains and is involved in protein targeting and multipro-
Protein Expression and Purificationtein assembly. Notably, it is overexpressed in gastric
A syntenin clone was obtained from American Tissue and Culture
and breast cancer cell lines, suggesting that its function Collection (ATCC 72537). The DNA fragment coding for PDZ2 (197–
contributes to cytoskeleton regulation and cell migra- 273) was amplified by PCR and cloned into a GST-fusion expression
vector containing the TEV (tobacco etch virus) protease cleavagetion. Syntenin binds biologically important receptors
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site (Sheffield et al., 1999). This construct was used for expression Received: February 13, 2003
Revised: March 3, 2003of protein samples for the crystallization of uncomplexed PDZ2. To
obtain a shorter version of PDZ2 (197–270), a stop codon (TGA) was Accepted: March 27, 2003
Published: July 1, 2003introduced after Met270 by the QuikChange method (Stratagene).
This step was necessary to prevent intermolecular interactions be-
tween the PDZ2 domains, in which one molecule bound another via References
the terminal Phe (see text). Both versions of the PDZ2 domain were
expressed in E. coli BL21 strain (Stratagene) and purified using Bezprozvanny, I., and Maximov, A. (2001). Classification of PDZ
glutathione-Sepharose 4B column (Amersham Pharmacia Biotech). domains. FEBS Lett. 509, 457–462.
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